Navigation Links
China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) 'Beijing Management Summit'
Date:9/1/2008

HAIKOU, Hainan, China, Sept. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio/pharmaceutical products in China, today announced attendance at the Susquehanna Financial Group, LLP (SIG)"Beijing Management Summit" held in Beijing, PRC, from the 10th to the 12th of September 2008.

Attending this conference and available for one-on-one meetings with analysts and investors throughout the conference will be senior management from the company including the President and CEO, Ms Zhilin Li, and the CFO, Mr Xinhua Wu.

Ms Zhilin Li has been CEO of China Pharma since 2005. She also founded and has been CEO of Hainan Helpson Medicine & Biotechnique Ltd. (Helpson; a wholly owned subsidiary of China Pharma Holdings, Inc.) since 1993. Mr Xinhua Wu has been CFO of Helpson since 1999 and CFO of China Pharma since 2005.

Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and growth strategy.

For more information on the conference, please visit the SIG website.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio/pharmaceutical products in China that treat a wide range of conditions, including infections, liver disease, cardio/cerebrovascular and CNS diseases, and other prevalent diseases.

Helpson is a specialty pharmaceutical company headquartered in Haikou City, Hainan Province, China.

For more information, please contact:

Diana

China Pharma Holdings, Inc.

Tel: +86-898-6681-1730

Fax: +86-898-6681-9024

Email: hps@chinapharmaholdings.com


'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017 http://www.Financialbuzz.com ... of leading causes of death worldwide. There were 8.2 ... of cancer related deaths increased gradually over time, the ... rate of various cancers continues to drive demand of ... by Global Market Insights, Inc. cancer biological therapy market size ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... CALABASAS, Calif. , Jan. 19, 2017 /PRNewswire/ ... Mathias Schmidt , Ph.D., as chief executive ... board of directors. Dr. Schmidt brings to ArmaGen more ... on the research and development of biotherapeutics and ... biopharmaceutical executive with the diverse experience and skillset ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... of drug and device development, and Prism Clinical Research , a leader ... announced Verified Clinical Trials (VCT) has been selected by both companies ...
Breaking Biology Technology:
(Date:12/15/2016)... LONDON , Dec. 15, 2016 /PRNewswire/ ... the driving experience, health wellness and wellbeing ... As one in three new passenger vehicles ... voice recognition, gesture recognition, heart beat monitoring, ... eyelid monitoring, facial monitoring, and pulse detection. ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):